Management of Failed Infrainguinal Revascularization with Absent Flow

Immediate Diagnostic Workup

Urgent duplex ultrasound (DUS) should be performed to assess graft patency (patent, threatened, or occluded) and to locate the specific segment responsible for failure, guiding immediate re‑intervention decisions. 1
DUS correlates strongly with clinical deterioration after both endovascular therapy and surgical bypass and reliably determines the hemodynamic significance of lesions. 2
A systolic velocity ratio ≥ 2.5 on DUS predicts symptom recurrence and the need for further intervention. 3

Ankle‑brachial index (ABI), toe‑brachial index (TBI), and pulse‑volume recordings (PVR) should be obtained to quantify the severity of hemodynamic compromise. 1
Transcutaneous oxygen pressure (TcPO₂) is essential when tissue loss is present; values > 40 mm Hg forecast successful wound healing, whereas lower values indicate the need for aggressive revascularization. 4
These non‑invasive tests help differentiate vascular from non‑vascular causes of symptoms and establish a baseline for post‑procedure comparison. 2

Classify patients as having claudication versus chronic limb‑threatening ischemia (CLTI) based on rest pain, non‑healing wounds, or gangrene persisting > 2 weeks. 5
Screen for acute limb ischemia (ALI) by evaluating the six “P” signs (pain, pallor, pulselessness, poikilothermia, paresthesia, paralysis) occurring within 2 weeks. 5
Presence of CLTI or ALI mandates urgent re‑intervention, whereas stable claudication permits more deliberate planning. 5

When DUS is insufficient, computed tomography angiography (CTA) provides 99 % sensitivity, 98 % specificity, and 98 % accuracy for detecting > 50 % stenoses. 4
Magnetic resonance angiography (MRA) offers comparable image quality without radiation or iodinated contrast and is especially useful for tibial vessel evaluation. 1
Both CTA and MRA can reduce procedural time, radiation exposure, and contrast volume during subsequent endovascular treatment. 2
Diagnostic catheter‑based angiography should be reserved for cases that will proceed directly to intervention, avoiding its use as a stand‑alone diagnostic test. 1

Identifying and treating symptomatic restenosis improves long‑term patency and limb‑salvage outcomes for both endovascular and surgical patients. 1
Mild‑to‑moderate atheromatous changes suggest progressive disease rather than acute thrombosis, supporting an endovascular revision approach. 5

Perform an immediate post‑procedure DUS to establish a “new baseline” and detect lesions not visualized on angiography that may require closer follow‑up. 3
If early follow‑up reveals persistent or recurrent disease, schedule surveillance DUS every 2–3 months rather than at routine longer intervals. 3
Intensive surveillance in critically threatened limbs has been shown to markedly improve limb‑salvage rates compared with clinical follow‑up alone. 3

Continue antiplatelet therapy and optimize cardiovascular risk factors—including statin use and smoking cessation—according to the 2024 ACC/AHA guideline recommendations. 5

Do not postpone re‑intervention in symptomatic patients solely because imaging shows only mild‑to‑moderate atherosclerosis; absent flow indicates hemodynamically significant disease requiring treatment. 1
In patients with diabetes or heavily calcified vessels, ABI alone may be falsely elevated; rely on TBI and TcPO₂ for accurate assessment. 4
Avoid routine surveillance angiography in asymptomatic patients, as it lacks supporting evidence. 2
Recognize that DUS can underestimate disease extent beyond the first significant stenosis; correlate imaging findings with clinical assessment. 1